Behavior of nursery/peer-reared and mother-reared rhesus monkeys from birth through 2 years of age

The behavior of 8 nursery/peer-reared and 16 mother-only reared rhesus macaques was observed between birth and 5 months of age, with follow-up studies conducted when the animals were 10–21 months old and living in large social groups. Nursery-reared neonates were more awake, active, and irritable than mother-only reared monkeys. From 1 to 5 months of age the nursery/peer-reared animals exhibited a greater variety of behaviors than the mother-only reared infants, which spent the majority of the time in ventral contact with mothers. As juveniles the groups were indistinguishable with the exception of more self-directed behaviors observed in the nursery/peer-reared monkeys. Both rearing conditions, by virtue of their atypicality, imposed restrictions on social development. The behavioral similarity of the juveniles while in the large social group may be a function of maturation or due to the rehabilitative effect of the large social group.     

Spore Load of Ascosphaera Species on Emerging Adults of the Alfalfa Leafcutting Bee, Megachile rotundata

The spore load of Ascosphaera species spores on larval chalkbrood cadavers and newly emergent adults of the alfalfa leafcutting bee, Megachile rotundata, was determined. The spore content of chalkbrood cadavers ranged from 3 × 10⁶ to 5 × 10⁸. Adults emerging through zero to nine cadavers carried spores on all body parts examined by scanning electron microscopy. Estimates of the total number of spores obtained from a series of adult washes ranged from 9 × 10⁴ to 8 × 10⁷. Some adult males which emerged through no cadavers carried 10⁴ to 10⁵ spores, indicating that nesting materials might also have been contaminated. However, the control of chalkbrood in commercial bee populations may not be accomplished simply by providing clean nesting materials as adults may still emerge through diseased larvae.     

Isolation and subregional mapping of a human cDNA clone detecting a common RELP on chromosome 12

Summary Peripheral blood lymphocytes from three patients with Down syndrome (DS; trisomy 21; aged 5–6 years) and three age-matched control children were studied for the induction of chromosomal aberrations and sister chromatid exchanges (SCEs).Cells in G₀ were exposed to bleomycin (20–100 g/ml) for 3 h, and then cultured in medium containing 5-bromodeoxyuridine and phytohemagglutinin for 66 h. By the sister chromatid differential staining method, chromosome analyses were performed on metaphase cells that had divided one, two, or three or more times after treatment. The results indicate that DS cells exposed to bleomycin are hypersensitive to the production of dicentric and ring chromosomes compared to normal cells. Bleomycin also led to a dose-related increase in the frequency of SCEs, but no difference was found between the SCE frequencies in DS or normal lymphocytes exposed to bleomycin.     

Linear analogues derived from the first EGF‐like domain of human blood coagulation factor VII: enhanced inhibition of FVIIa/TF complex activity by backbone modification through aspartimide formation

Coagulation factor VII bound to its cofactor tissue factor is the physiological initiator of blood coagulation. The interaction between factor VII and tissue factor involves all four of the structural modules found in factor VII, with the most significant contribution coming from the first EGF‐like domain. In this study, the synthesis and biological activity of several analogues derived from the first EGF‐like domain of FVII comprising the sequence 45–83 are reported on. The six cysteine residues found in the native protein were replaced by Abu. The peptides were isolated from a multicomponent mixture following standard Fmoc solid phase synthesis. Purification and characterisation of the heterogeneous product showed that aspartimide formation was a major side‐reaction, occurring predominantly at the Asp⁴⁶‐Gly⁴⁷ and Asn⁵⁷‐Gly⁵⁸ dipeptides. Although relatively common in peptide synthesis, the extent to which this side‐reaction had taken place was considered surprising. Reported herein are the analytical methods used to isolate and characterise several of the modified products. Also, the inhibitory effect of these peptides on the formation and enzymatic activity of the factor VIIa/tissue factor complex have been compared. Surprisingly, the peptide containing an iso‐Asp residue at position 57 possessed 66‐fold higher inhibitory activity compared with the original target peptide. A possible explanation for this increase in observed activity is presented. Copyright © 1999 European Peptide Society and John Wiley & Sons, Ltd.     

Reduction of Root-Knot Nematode, Meloidogyne javanica, and Ozone Mass Transfer in Soil Treated with Ozone

Ozone gas (O(3)) is a reactive oxidizing agent with biocidal properties. Because of the current phasing out of methyl bromide, investigations on the use of ozone gas as a soil-fumigant were conducted. Ozone gas was produced at a concentration of 1% in air by a conventional electrical discharge O(3) generator. Two O(3) dosages and three gas flow rates were tested on a sandy loam soil collected from a tomato field that had a resident population of root knot nematodes, Meloidogyne javanica. At dosages equivalent to 50 and 250 kg of O(3)/ha, M. javanica were reduced by 24% and 68%, and free-living nematodes by 19% and 52%, respectively. The reduction for both M. javanica and free-living nematodes was dosage dependent and flow rate independent. The rates of O(3) mass transfer (OMT) through three soils of different texture were greater at low and high moisture levels than at intermediate ones. At any one soil moisture level, the OMT rate varied with soil texture and soil organic matter content. Results suggest that soil texture, moisture, and organic matter content should be considered in determining O(3) dosage needed for effective nematode control.     

Low Resistance to First and Second Line Anti-Tuberculosis Drugs among Treatment Naive Pulmonary Tuberculosis Patients in Southwestern Uganda

BackgroundThere are limited data on region-specific drug susceptibility of tuberculosis (TB) in Uganda. We performed resistance testing on specimens collected from treatment-naive patients with pulmonary TB in Southwestern Uganda for first and second line anti-TB drugs. We sought to provide data to guide regional recommendations for empiric TB therapy.MethodsArchived isolates, obtained from patients at Mbarara Regional Referral Hospital from February 2009 to February 2013, were tested for resistance to isoniazid and rifampicin using the MTBDRplus and Xpert MTB/RIF assays. A subset of randomly selected isolates was tested for second line agents, including fluoroquinolones (FQs), aminoglycosides, cyclic peptides, and ethambutol using the MTBDRsl assay. We performed confirmatory testing for FQ resistance using repeated MTBDRsl, the Mycobacteria growth indicator tube (MGIT) assay, and sequencing of the gyrA and gyrB genes.ResultsWe tested isolates from 190 patients. The cohort had a median age of 33 years (IQR 26-43), 69% (131/190) were male, and the HIV prevalence was 42% (80/190). No isolates (0/190) were rifampicin-resistant and only 1/190 (0.5%) was isoniazid-resistant. Among 92 isolates tested for second-line drug resistance, 71 (77%) had interpretable results, of which none were resistant to aminoglycosides, cyclic peptides or ethambutol. Although 7 (10%) initially tested as resistant to FQs by the MTBDRsl assay, they were confirmed as susceptible by repeat MTBDRsl testing as well as by MGIT and gyrase gene sequencingConclusionWe found no MDR-TB and no resistance to ethambutol, FQs, or injectable anti-TB drugs in treatment naïve patients with pulmonary TB in Southwestern Uganda. Standard treatment guidelines for susceptible TB should be adequate for most patients with TB in this population. Where possible, molecular susceptibility testing methods should be routinely validated by culture methods.     

Characterization of cellular DGK-θ

In this report we have summarized the data regarding the regulation of DGK-θ by two phospholipids: PtdSer and PtdOH. Our previous data has shown that stimulation of quiescent fibroblasts with a potent mitogen (α-thrombin) leads to an increase in nuclear localized DGK-θ ([Bregoli et al., 2001] and [Bregoli et al., 2002]), as has been seen in neuronal cells ([Tabellini et al., 2003] and [Tabellini et al., 2004]). Furthermore, these previous studies demonstrated that DGK-θ is actually localized to the nuclear matrix ([Bregoli et al., 2002] and [Tabellini et al., 2003]). As we have also previously shown that PtdSer and PtdOH modulate DGK-θ activity ([Tu-Sekine et al., 2006] and [Tu-Sekine et al., 2007]), we examined the phospholipid composition of the nuclear matrix as well as the phospholipid composition of the intact nuclei and non-nuclear membranes. This analysis has revealed that there are phospholipids in the “matrix” of nuclei and the composition of these lipids largely resembles those of the other membranes. The physical form and localization of the matrix-associated lipids has not been established, though the nearly identical percent composition of the non-nuclear membranes and the nuclear matrix lend credence to the hypothesis that at least some of the internal nuclear lipid is derived from invaginations of the cellular membranes through the nuclear interior known as nuclear tubules ([Fricker et al., 1997] and [Lee et al., 2006]).An important finding resulting from this analysis is that the nuclear envelope is enriched in PtdSer relative to the nuclear matrix and to cellular membranes, and that over-expression of DGK-θ reduces both the PtdSer and PtdEth levels of the nuclear envelope. While the mechanism behind these fluctuations is unknown, the data are consistent with a DGK-regulated phosphatidylcholine-dependent phosphatidylserine synthase (PSS-1) (EC 2.7.8.8) activity at the nuclear envelope. PtdSer synthesis in mammalian cells proceeds by headgroup exchange with PtdCho or PtdEth, catalyzed by PSS-1 or PSS-2, respectively. Interestingly, the decrease in both PtdSer and PtdEth at the nuclear membrane mirrors effects observed in the CHO-K1 mutant cell lines M.6.1.1 and PSA-3, which have been shown to be deficient in PSS-1 activity (Vance and Steenbergen, 2005). While there is very little information on the regulation of mammalian PSS enzymes, phosphorylation has been shown to regulate serine exchange activities in rat brain (Kanfer et al., 1988), and we have shown that nuclear DGK-θ regulates the exit of PKC-α from the nucleus (see regulation of PKC-α). To our knowledge, there is currently no reported study of nuclear phosphatidylyserine synthases.One other notable fluctuation in cellular lipids from DGK-θ expression is an increase in plasmalogen-PtdEth in both the NNM and nuclear matrix. While the majority of studies conducted on plasmalogen synthesis agree in that there is an almost complete dependence on the classical CDP-ethanolamine pathway to provide the headgroup for precursor plasmalogen synthesized in the peroxisome, there are several studies utilizing radiolabeled serine that report approximately 20–30% of cellular plasmalogen-PtdEth can be derived from PtdSer in at least some cell models ([Yorek et al., 1985] and [Xu et al., 1991]). Whether nuclear PtdSer-derived PtdEth a precursor for the membrane plasmalogen-PtdEth present in DGK-θ expressing cells is not evident from the data presented here, though one potential mechanism for an increase in flux through this pathway could be an increase in PtdSer-derived PtdEth. At this juncture we can only speculate on the cause of the lipid perturbations, and further work is required to support our hypothesis that DGK-θ impacts PtdSer and plasmalogen metabolism.The physiological role for nuclear DGK-θ has remained a mystery. It has long been recognized that an obvious role for DGKs is to modulate cellular levels of its DAG substrate thereby modulating DAG-sensitive proteins like such as many PKCs (Merida et al., 2008). Our data support this notion as suppression of DGK-θ, either by expression of RhoA or a dominant-negative construct of DGK-θ, leads to a sustained increase in nuclear PKC-α (Fig. 2).In addition to the regulation by PtdSer and PtdOH, we report here that the regulation of nuclear DGK-θ by RhoA is modulated by a Class I PI 3-kinase. Furthermore, we have examined the effect of various inhibitors on the activity of DGK-θ in lysates over-expressing this isoform. This is important as many studies often use pharmacologic inhibitors to determine the role of selected enzymes in signaling pathways. While this approach is useful for comparative analyses, there are no data pertaining to the effect of these inhibitors on DGK-θ. We have found that one well-established PI-PLC inhibitor, U73122, but not its inactive analog U73343, competitively inhibits this isoform with respect to its diacylglycerol (DAG) substrate. These data indicate that studies designed to examine the role of PI-PLC in modulating DGK-θ activity using this inhibitor should be interpreted with caution.     

Transgenic Increase in N-3/N-6 Fatty Acid Ratio Reduces Maternal Obesity-Associated Inflammation and Limits Adverse Developmental Programming in Mice

Maternal and pediatric obesity has risen dramatically over recent years, and is a known predictor of adverse long-term metabolic outcomes in offspring. However, which particular aspects of obese pregnancy promote such outcomes is less clear. While maternal obesity increases both maternal and placental inflammation, it is still unknown whether this is a dominant mechanism in fetal metabolic programming. In this study, we utilized the Fat-1 transgenic mouse to test whether increasing the maternal n-3/n-6 tissue fatty acid ratio could reduce the consequences of maternal obesity-associated inflammation and thereby mitigate downstream developmental programming. Eight-week-old WT or hemizygous Fat-1 C57BL/6J female mice were placed on a high-fat diet (HFD) or control diet (CD) for 8 weeks prior to mating with WT chow-fed males. Only WT offspring from Fat-1 mothers were analyzed. WT-HFD mothers demonstrated increased markers of infiltrating adipose tissue macrophages (P<0.02), and a striking increase in 12 serum pro-inflammatory cytokines (P<0.05), while Fat1-HFD mothers remained similar to WT-CD mothers, despite equal weight gain. E18.5 Fetuses from WT-HFD mothers had larger placentas (P<0.02), as well as increased placenta and fetal liver TG deposition (P<0.01 and P<0.02, respectively) and increased placental LPL TG-hydrolase activity (P<0.02), which correlated with degree of maternal insulin resistance (r = 0.59, P<0.02). The placentas and fetal livers from Fat1-HFD mothers were protected from this excess placental growth and fetal-placental lipid deposition. Importantly, maternal protection from excess inflammation corresponded with improved metabolic outcomes in adult WT offspring. While the offspring from WT-HFD mothers weaned onto CD demonstrated increased weight gain (P<0.05), body and liver fat (P<0.05 and P<0.001, respectively), and whole body insulin resistance (P<0.05), these were prevented in WT offspring from Fat1-HFD mothers. Our results suggest that reducing excess maternal inflammation may be a promising target for preventing adverse fetal metabolic outcomes in pregnancies complicated by maternal obesity.